Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
1 other identifier
interventional
878
1 country
15
Brief Summary
The conventional sonography is frequently used to detect incidental focal liver lesions because of its availability, innocuity and low cost. Nevertheless, sensibility and specificity of conventional sonography does not exceed 70% for tumoral affections. Consequently the interest of this practice must be reconsidered by studying its ratio cost/diagnosis contribution. These limitations of conventional sonography have led to the use of other imaging modalities and invasive or costly procedures such as computed tomography (CT), magnetic resonance imaging (MRI) or biopsy. The availability of real-time contrast-enhanced ultrasound imaging (CEUS) has changed the strategy in the characterization of focal liver lesions, on healthy or cirrhotic liver in a neoplastic context or not, without inconvenience for the patient. The aim of the present study is to evaluate the place of CEUS in term of diagnostic relevance and catch of load cost, in the characterization of focal liver lesions detected but not characterized by CT or conventional sonography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2005
Typical duration for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 21, 2005
CompletedFirst Posted
Study publicly available on registry
October 24, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedDecember 23, 2025
December 1, 2025
1.7 years
October 21, 2005
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medical and economic interest of CEUS
Secondary Outcomes (3)
Method acceptability
Contrast-enhanced ultrasound sonography tolerance
Harmony inter-readers
Interventions
Eligibility Criteria
You may qualify if:
- Target focal liver lesion of size lower than 10 cm and higher than 5 mm detected by conventional ultrasonography
You may not qualify if:
- Patients with acute coronary syndrome or clinically unstable ischaemic cardiac disease, including: myocardial infarction, recent coronary artery intervention, acute cardiac failure (within last month), acute endocarditis and prosthetic valves.
- Pregnant and lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Tourslead
- Ministry of Health, Francecollaborator
Study Sites (15)
CHRU d'ANGERS
Angers, 49033, France
Hôpital Saint-Jacques, CHRU Besancon
Besançon, 25000, France
Hôpital Saint-André, CHRU Bordeaux
Bordeaux, 33075, France
Hôpital Beaujon, Assistance Publique Hôpitaux de Paris
Clichy, 92118, France
Hospices Civils de Lyon
Lyon, 69003, France
Hôpital Saint-Eloi, CHRU Montpellier
Montpellier, 34295, France
Hôpital Pitié Salpétrière, Assistance Publique Hôpitaux de Paris
Paris, 75651, France
Hôpital Necker, Assistance Publique Hôpitaux de Paris
Paris, 75743, France
Hôpital La Milétrie, CHRU Poitiers
Poitiers, 86000, France
Hôpital Robert Debré, CHRU Reims
Reims, 51092, France
Hôpital Nord, CHRU Saint-Etienne
Saint-Etienne, 42055, France
Hôpital Bretonneau, CHRU Tours
Tours, 37044, France
Service de Radiologie, Hôpital d'Enfants de Brabois
Vandœuvre-lès-Nancy, 54511, France
Hôpital Paul Brousse, Assistance Publique Hôpitaux de Paris
Villejuif, 94804, France
Institut Gustave Roussy
Villejuif, 94805, France
Related Publications (8)
Kim TK, Choi BI, Hong HS, Choi BY, Han JK. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol. 2000 Nov;26(9):1439-44. doi: 10.1016/s0301-5629(00)00268-4.
PMID: 11179618BACKGROUNDAlbrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology. 2003 May;227(2):361-70. doi: 10.1148/radiol.2272011833. Epub 2003 Mar 20.
PMID: 12649417BACKGROUNDQuaia E, Bertolotto M, Forgacs B, Rimondini A, Locatelli M, Mucelli RP. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol. 2003 Mar;13(3):475-83. doi: 10.1007/s00330-002-1670-1. Epub 2002 Sep 26.
PMID: 12594549BACKGROUNDBernatik T, Becker D, Neureiter D, Hansler J, Frieser M, Schaber S, Hahn EG, Strobel D. [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents]. Ultraschall Med. 2003 Jun;24(3):175-9. doi: 10.1055/s-2003-40060. German.
PMID: 12817311BACKGROUNDBasilico R, Blomley MJ, Harvey CJ, Filippone A, Heckemann RA, Eckersley RJ, Cosgrove DO. Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radiol. 2002 Mar;41(3):184-91. doi: 10.1016/s0720-048x(01)00459-4.
PMID: 11861092BACKGROUNDLeen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol. 2002 Mar;41(3):200-6. doi: 10.1016/s0720-048x(01)00457-0.
PMID: 11861094BACKGROUNDTranquart F, Bleuzen A, Tchuenbou J. [Contrast ultrasound imaging in focal liver lesions: diagnostic value and guidelines]. J Radiol. 2004 May;85(5 Pt 2):680-9. doi: 10.1016/s0221-0363(04)97649-4. French.
PMID: 15238869BACKGROUNDTranquart F, Correas JM, Ladam Marcus V, Manzoni P, Vilgrain V, Aube C, Elmaleh A, Chami L, Claudon M, Cuilleron M, Diris B, Garibaldi F, Lucidarme O, Marion D, Beziat C, Rode A, Tasu JP, Trillaud H, Bleuzen A, Le Gouge A, Giraudeau B, Rusch E. [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study]. J Radiol. 2009 Jan;90(1 Pt 2):109-22. doi: 10.1016/s0221-0363(09)70089-7. French.
PMID: 19212279RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Michel CORREAS, Dr
Necker Hospital
- STUDY DIRECTOR
François TRANQUART, Pr
University Hospital, Tours
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2005
First Posted
October 24, 2005
Study Start
April 1, 2005
Primary Completion
December 1, 2006
Study Completion
August 1, 2007
Last Updated
December 23, 2025
Record last verified: 2025-12